Desafios da indústria farmacêutica brasileira

Detalhes bibliográficos
Autor(a) principal: Pinto,Angelo C.
Data de Publicação: 2013
Outros Autores: Barreiro,Eliezer J.
Tipo de documento: Artigo
Idioma: por
Título da fonte: Química Nova (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422013001000012
Resumo: The paper traces a panorama of the development of new drugs and hopes to contribute for Brazil to become a player in the discovery of new drugs. Brazil is the sixth world market retail consumer of medicines prone to expansion, has a pharmaceutical industry focused on the production of generics and a very large number of undergraduate courses in Pharmacy. The national industry has grown over the last decade after the Generics Act 9787/99. Despite these positive aspects, a number of bottlenecks prevent Brazilian pharmaceutical industry to invest in the development of new drugs. There are, however, a number of initiatives to reduce the dependence on imported generic drugs. It is a very good start for the development of new pharmaceutical drugs.
id SBQ-3_a54a95b63a92b6f6016629e4863c5bcf
oai_identifier_str oai:scielo:S0100-40422013001000012
network_acronym_str SBQ-3
network_name_str Química Nova (Online)
repository_id_str
spelling Desafios da indústria farmacêutica brasileiraBrazilian pharmaceutical industrygeneric medicinesbottlenecks of the Brazilian pharmaceutical industryThe paper traces a panorama of the development of new drugs and hopes to contribute for Brazil to become a player in the discovery of new drugs. Brazil is the sixth world market retail consumer of medicines prone to expansion, has a pharmaceutical industry focused on the production of generics and a very large number of undergraduate courses in Pharmacy. The national industry has grown over the last decade after the Generics Act 9787/99. Despite these positive aspects, a number of bottlenecks prevent Brazilian pharmaceutical industry to invest in the development of new drugs. There are, however, a number of initiatives to reduce the dependence on imported generic drugs. It is a very good start for the development of new pharmaceutical drugs.Sociedade Brasileira de Química2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422013001000012Química Nova v.36 n.10 2013reponame:Química Nova (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0100-40422013001000012info:eu-repo/semantics/openAccessPinto,Angelo C.Barreiro,Eliezer J.por2013-11-27T00:00:00Zoai:scielo:S0100-40422013001000012Revistahttps://www.scielo.br/j/qn/ONGhttps://old.scielo.br/oai/scielo-oai.phpquimicanova@sbq.org.br1678-70640100-4042opendoar:2013-11-27T00:00Química Nova (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv Desafios da indústria farmacêutica brasileira
title Desafios da indústria farmacêutica brasileira
spellingShingle Desafios da indústria farmacêutica brasileira
Pinto,Angelo C.
Brazilian pharmaceutical industry
generic medicines
bottlenecks of the Brazilian pharmaceutical industry
title_short Desafios da indústria farmacêutica brasileira
title_full Desafios da indústria farmacêutica brasileira
title_fullStr Desafios da indústria farmacêutica brasileira
title_full_unstemmed Desafios da indústria farmacêutica brasileira
title_sort Desafios da indústria farmacêutica brasileira
author Pinto,Angelo C.
author_facet Pinto,Angelo C.
Barreiro,Eliezer J.
author_role author
author2 Barreiro,Eliezer J.
author2_role author
dc.contributor.author.fl_str_mv Pinto,Angelo C.
Barreiro,Eliezer J.
dc.subject.por.fl_str_mv Brazilian pharmaceutical industry
generic medicines
bottlenecks of the Brazilian pharmaceutical industry
topic Brazilian pharmaceutical industry
generic medicines
bottlenecks of the Brazilian pharmaceutical industry
description The paper traces a panorama of the development of new drugs and hopes to contribute for Brazil to become a player in the discovery of new drugs. Brazil is the sixth world market retail consumer of medicines prone to expansion, has a pharmaceutical industry focused on the production of generics and a very large number of undergraduate courses in Pharmacy. The national industry has grown over the last decade after the Generics Act 9787/99. Despite these positive aspects, a number of bottlenecks prevent Brazilian pharmaceutical industry to invest in the development of new drugs. There are, however, a number of initiatives to reduce the dependence on imported generic drugs. It is a very good start for the development of new pharmaceutical drugs.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422013001000012
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422013001000012
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 10.1590/S0100-40422013001000012
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Química Nova v.36 n.10 2013
reponame:Química Nova (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Química Nova (Online)
collection Química Nova (Online)
repository.name.fl_str_mv Química Nova (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv quimicanova@sbq.org.br
_version_ 1750318115458121728

Registros relacionados